CAS 73603-40-4

(2R,3S,4S,5S,6R)-6-[(2S,3S,4R,5S,6S)-3-acétamido-2-[(2R,3S,4R,5S,6R)-6-[(2S,3S,4R,5S,6S)-3-acétamido-2-[(2R,3S,4R,5S,6R)-6-[(3S,4R,5S,6S)-3-acétamido-2,5-dihydroxy-6-(hydroxyméthyl)tetrahydropyran-4-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-

Formule : C₄₂H₆₅N₃O₃₄

InChI : InChI=1/C42H65N3O34/c1-7(49)43-13-26(16(52)10(4-46)69-37(13)68)72-41-24(60)21(57)29(32(78-41)35(64)65)75-39-15(45-9(3)51)28(18(54)12(6-48)71-39)74-42-25(61)22(58)30(33(79-42)36(66)67)76-38-14(44-8(2)50)27(17(53)11(5-47)70-38)73-40-23(59)19(55)20(56)31(77-40)34(62)63/h10-33,37-42,46-48,52-61,68H,4-6H2,1-3H3,(H,43,49)(H,44,50)(H,45,51)(H,62,63)(H,64,65)(H,66,67)/t10-,11-,12-,13-,14-,15-,16+,17+,18+,19-,20-,21+,22+,23-,24-,25-,26+,27+,28+,29-,30-,31+,32+,33+,37?,38-,39-,40+,41+,42+/m0/s1

Code InChI : LFAUBHLTGUFQPC-PQHHSPKYSA-N

SMILES : CC(=O)N[C@H]1[C@H]([C@@H]([C@@H](O[C@H]1O[C@H]2[C@@H]([C@@H]([C@@H](O[C@H]2C(=O)O)O[C@@H]3[C@@H]([C@@H](O[C@H]([C@H]3O)CO)O[C@H]4[C@@H]([C@@H]([C@@H](O[C@H]4C(=O)O)O[C@H]5[C@@H]([C@@H](OC([C@H]5NC(=O)C)O)CO)O)O)O)NC(=O)C)O)O)CO)O)O[C@H]6[C@H]([C@H]([C@@H]([C@@H](O6)C(=O)O)O)O)O

Hyaluronate Hexasaccharide

CAS : 73603-40-4

Formule : C₄₂H₆₅N₃O₃₄

Degré de pureté : >95.0%(HPLC)

Couleur et forme : White to Almost white powder to crystal

Masse moléculaire : 1,155.97

Ref: 3B-H1285

Hyaluronate Hexasaccharide

CAS : 73603-40-4

Hyaluronate Hexasaccharide

Formule : C₄₂H₆₅N₃O₃₄

Degré de pureté : >95%

Masse moléculaire : 1155.97

Ref: 54-OR1079032

Hyaluronate Hexasaccharide ,

CAS : 73603-40-4

Formule : C₄₂H₆₅N₃O₃₄

Degré de pureté : 98%

Masse moléculaire : 1155.9652

Ref: IN-DA003QYA

Hyaluronic acid hexasaccharide

CAS : 73603-40-4

Hyaluronic acid is a polysaccharide containing repeating disaccharide units of β-1,3-N-acetyl glucosamine and β-1, 4-glucuronic acid. A series of unsaturated oligosaccharides (oligouronic acids) are released from hyaluronic acid by the action of hyaluronidase on umbilical cord (Weissman, 1954). This hexasaccharide and other enzymatically produced polymer homologs have been of value in the study of hyaluronic acid metabolism in healthy and diseased tissues (Hascall, 2019).

Formule : C₄₂H₆₅N₃O₃₄

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 1,155.97 g/mol

Ref: 3D-OH58157